Lisa Anne Boothby, PharmD, BCPS Director of Pharmacy, Dukes Memorial Hospital.

Slides:



Advertisements
Similar presentations
Medication Management
Advertisements

MEDICAL HOME 1/2009 Mary Goldman, D.O., President of MAOFP.
November 26, Fall Forum Alberta’s Pharmaceutical Strategy and Programs Policy Recommendations.
Disease State Management The Pharmacist’s Role
The Value of Medication Therapy Management Services
UAMC – Discharge Medication Optimization Lauren Miller, PharmD. Instructor University of Arizona College of Pharmacy Clinical Staff Pharmacist Ambulatory.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Title slide Georgia Hospital Engagement Network Healthcare Acquired Condition Affinity Group June 19, 2013 Presenter: Dr. Teresa Pounds, PharmD, BCNSP.
IMPACTS OF PHARMACIST’S ROLES ON REDUCING READMISSION RATE AND PROMOTING PATIENT SAFETY IN PEDIATRIC CARDIAC PATIENTS Manita Suriyarangsee Monwarat Laohajeeraphan.
Hospital Pharmacy Payam Parchamazad, PharmD Staff Pharmacist
Medication Therapy Management Linda Mach, PharmD Bartell Drugs Community Practice Resident February 26, 2010.
Pharmacy 483 Outcomes & Cost Management in Pharmacy Practice Janet Kelly, Pharm.D., BC-ADM February 22, 2005.
Omnibus Budget Reconciliation Act (OBRA-90) Goal To save money.
Ambulatory care Prepared by: Nehad Ahmed. Ambulatory care is Primary care-based services and services provided from office-based specialists and hospital.
Engaging the C-suite to Advance Pharmacy Practice Providing quality patient care through progressive pharmacy practice Safety, Quality, and the Pharmacy.
Medication Management: Why it Should be Part of Every Benefit Plan Solutions in Drug Plan Management September 8, 2011 Deb Saltmarche BScHons(Pharm), RPh,
Clinical Pharmacy Basma Y. Kentab MSc..
Sutter Care Coordination Program (SCCP) Supporting Patients and Practitioners in Optimizing Health.
Care Coordination What is it? How Do We Get Started?
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
Pharmacy and Therapeutics Committee
Mental Health Clinical Pharmacy Services and Pilot at Regions Hospital
Introduction To Pharmacy Practice
HRET/K-HEN Readmissions Race Office Hour Building a Multidisciplinary Care Transitions Team January 25, 2013.
Medication Reconciliation: The Inpatient Hospitalist Perspective
Primary Care Workforce Summit November 29, 2012 Country Springs Hotel, Waukesha Primary Care Workforce Summit Pharmacy Perspective Kate Hartkopf, PharmD.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
In Which Areas Have Clinical Pharmacists Been the Most Successful in Patient Care ? Hospital inpatient unit (wards) –Therapeutic drug monitoring –Anticoagulation.
Linda Y. Radke, Pharm.D., BCPS, FASHP Salina Regional Health Center
The Value of Medication Therapy Management Services.
Coordinating Care Sierra Dulaney Lisa Fassett Morgan Little McKenzie McManus Summer Powell Jackie Richardson.
Interdisciplinary Teamwork in a Transitional Primary Care Clinic Tamara Malm, PharmD, MPH, BCPS September 18, 2015.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Medication Therapy Management Programs in Community Pharmacy Community Pharmacy October 17, 2006 Kurt A. Proctor, Ph.D., RPh Chief Operating Officer Community.
Emtenan AlHarbi,Mcs Clinical pharmacist
Latino Health Summit Presentation
Transitions of Care: Using Pharmacists as Part of Team Based Care Care Transformation Collaborative of R.I. TARA HIGGINS, PHARMD, CDOE, CVDOE CLINICAL.
Using a Novel Two-Pronged Pharmacy Model in a High-Risk Care Management Program to Address Medication Reconciliation and Access Kakoza RM 1, 2, De Leon.
ASSESSING THE FEASIBILITY OF ANTIBIOTIC MANAGEMENT SERVICES THROUGH PROSPECTIVE EVALUATION ABSTRACT PURPOSE: The inappropriate and unnecessary use of antibiotics.
The Tahoe/Carson Valley Transitions in Care Collaborative “A Solution for Improved Care Management in Rural Environments”
Introduction.
Hospital Pharmacy in Canada Report Data Trends New Frontline Staff Surveys Your Suggestions Kevin Hall B. Sc. Pharm., Pharm. D., FCSHP Clinical Associate.
MEDICATION MANAGEMENT P&T COMMITTEE AND FORMULARY MANAGEMENT EMTENAN ALHARBI, Msc CLINICAL PHARMACIST.
Multidisciplinary Diabetes Team Activities in a 196 Bed Community Hospital Robin Southwood, Pharm.D, CDE and Beth Melvin, RD, MS, CDE.
In addition to promoting Environmental Stewardship, there are regulations that apply to the management and disposal of pharmaceutical wastes What are healthcare.
Terry McInnis, MD MPH President- Blue Thorn, Inc - Mobile Co-Chair- Center for.
Transforming Care in Patient Centered Medical Home and Accountable Care Organization Hae Mi Choe, PharmD Director, Pharmacy Innovations & Partnerships.
Pharmaceutical Society of Ireland – The Pharmacy Regulator The Role of the Pharmacist in Self Care Telephone: Shrewsbury Rd Fax:
MTM Medication Therapy Management. What is Medication Therapy Management? From 1996 to 2006, the number of prescription medications dispensed increased.
The Medicines Adherence and Waste Challenge Carol Roberts Director of Strategic Prescribing EAHSN and PrescQIPP.
GB.DRO f, date of preparation: January 2010 Dartford and Gravesham NHS Trust Pharmacy Services in Hospital.
Michela C.C. Fiori, Pharm.D. PGY1 Pharmacy Resident, Penobscot Community Health Care Outcomes of a Pharmacist-Driven Education Program For Residents Discharged.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
MTM USER GROUP BEST PRACTICES AND OTHER STUFF THAT WORKS.
Collaborative Pilot Project: Connecting EMRs with the IL PMP to Improve Medication Safety IL Prescription Monitoring Program IHA’s Institute for Innovations.
Care Transitions for Medication Safety in the Community
Medication Therapy Management (MTM)
Inventory Management Chapter 13.
of Patients with Acute Myocardial Infarction (AMI)
Strategies to Modernize State Medicaid Programs, Utah’s Medicaid Transformation By Lisa V. Hulbert R.Ph. Transformation Program Manager Utah Medicaid.
Optimizing Meds – Need for Systems Approach
ARKANSAS COMMUNITY PHARMACY ENHANCED SERVICES NETWORK
Community Hospital Pharmacy Practice January 29, 2004
The Path to Provider Status
UNT Health Clinical Pharmacist Services
Provider and Member Education in Managed Care Pharmacy
Pharmacy practice experience I
2019 Model of Care Training University of Maryland Medical Systems Health Plans, Inc. Proprietary and Confidential.
Pharmacy practice and the healthcare system Ola Ali Nassr
Presentation transcript:

Lisa Anne Boothby, PharmD, BCPS Director of Pharmacy, Dukes Memorial Hospital

 Demonstrate the value of clinical pharmacy services to decrease 30-day readmission rates  Outline the pharmacist’s role in reducing medical waste  Detail ethical issues associated with drug shortage management

 Clinical pharmacy services  Inpatient and outpatient settings  Improve patient outcomes

 Patient Accountability and Affordable Care Act  Pharmacists are “other healthcare providers”  Social Security Act  Part B versus Part D  Three MTM billing codes  Private insurance reimbursement follows Smock N. Affordable Care Act Regards Pharmacists as Health Care Providers, Not Just Prescription Dispensers. Available at URL: Regards-Pharmacists-as-Health-Care-Providers-Not-Just-Prescription-Dispensershttp:// Regards-Pharmacists-as-Health-Care-Providers-Not-Just-Prescription-Dispensers

 Capitated healthcare precede reimbursement  May decrease need for pharmacy billing  Share in savings once minimum achieved  Accountable care organizations  Not all hospitals have embraced  Pilot programs Daigle L. Pharmacists Role in Accountable Care Organizations. ASHP Policy Analysis. ASHP, 2011.

 Providers accountable  Achieving quality  Reductions in rate of spending growth  Physician led with many payer arrangements  National Committee for Quality Assurance  Established ACO criteria  7 categories with 4 levels Daigle L. Pharmacists Role in Accountable Care Organizations. ASHP Policy Analysis. ASHP, 2011.

To reach critical mass  Incorporate multiple payers or multiple hospitals  Apply for a CMS wavier to include Medicaid patients Daigle L. Pharmacists Role in Accountable Care Organizations. ASHP Policy Analysis. ASHP, 2011.

 Patient centered medical homes  Led by physician  Include pharmacist, nurse and other health care practitioners  Treat patient with chronic conditions  Prevent adverse events and optimize therapy  Team ensures all health care needs are met Daigle L. Pharmacists Role in Accountable Care Organizations. ASHP Policy Analysis. ASHP, 2011.

 Improve medication management  Preventing hospital readmissions  Decreases revenue in a traditional hospital budgetary model Daigle L. Pharmacists Role in Accountable Care Organizations. ASHP Policy Analysis. ASHP, 2011.

 Keep patients healthy and out of the hospital  VA collaborative practice model  Prescribing privileges  More than 20 years of success  Pharmacist credentialed providers

 Medication management  Preventing disease  Maintaining cardiovascular health  Preventing end organ damage  Medication compliance, adherence  Therapeutic drug monitoring  Supportive care

 1 month study at Mission Hospital  735 bed community teaching hospital  Asheville, North Carolina  Pre-post design  2 weeks normal routine  2 weeks with clinical pharmacist Simone A. Physician-Pharmacist Team Improves Hospital Care. Published June 20, Available at

 Drug information  Discharge counseling  Medication interventions  Medication reconciliation  Filling discharge prescriptions  Submit discharge summaries Simone A. Physician-Pharmacist Team Improves Hospital Care. Published June 20, Available at

 15-day and 30-day readmission rates  Number of ED visits  Employee satisfaction surveys Simone A. Physician-Pharmacist Team Improves Hospital Care. Published June 20, Available at

 33% vs. 17% readmission within 30 days  11% vs. 2% readmission within 15 days  9% vs. 4% ED visits within 30 days Simone A. Physician-Pharmacist Team Improves Hospital Care. Published June 20, Available at

 Prospective cohort  729 patients over three months  Pharmacy medication reconciliation  30-day readmission rate  Polypharmacy and readmission rate Pal A., Babbott S, and Wilkinson T. Can the use of a discharge pharmacist significantly decrease 30-day readmissions? Hospital Pharmacy 2013;48(5):

 Med reconciliation and counseling  Decreased 30-day readmission rate  16.8% vs. 26%; p=0.006  Polypharmacy  More than 5 scheduled medications  Associated with increased readmission rates Pal A., Babbott S, and Wilkinson T. Can the use of a discharge pharmacist significantly decrease 30-day readmissions? Hospital Pharmacy 2013;48(5):

 Walgreens program  Reduces readmissions  Pharmacists oversee medication regimens  Transitions of care Walgreens Program Employs Pharmacists to Reduce Hospital Readmissions. November 20,

 Med review at admission and discharge  Bedside medication delivery  Counseling for patients and their caregivers  Regularly scheduled follow-up post discharge  24-7 support for discharged patients  Ensure follow up with physician  Ensure appropriate self care  Marian General and Lutheran Hospital Walgreens Program Employs Pharmacists to Reduce Hospital Readmissions. November 20,

 11 pharmacists  Vanderbilt University  Brigham and Women’s Hospital  Medication reconciliation  Time consuming  Most important contribution  Improving care transitions  Correct the admission medication history Haynes KT, Oberne A, Kripalani S. Pharmacists’ recommendations to improve care transitions. Ann Pharmacother 2012;46(9):

 Translation to a rural critical access hospital  Minimal resources  Decreased ED visits decreases admissions  Decreased revenue with traditional models  Next steps?

TARGETING TRANSITIONS  Project BOOST:  Project RED:  STAAR initiative:

 Medication reconciliation process  Physician and nurse driven  2 to 3 errors per each  Follow-up by pharmacy  Clarify and correct errors  Time intensive  Increased safety risk  Omissions  Delays and duplications

 Develop criteria for consultation  Greater than 10 scheduled medications  High-alert medications  Anticoagulants  Core-measure disease states

INCOMPATIBLE HAZARDOUS WASTE Aerosols Inhalers Oxidizers Silver nitrate REGULAR TRASH Outside packaging Empty items that once contained medication Shipping packaging Recycle paper, glass, plastic P-LISTED HAZARDOUS WASTE Coumadin plus wrapper Nicotine plus wrapper and peel HAZARDOUS WASTE Insulin Some vitamins and minerals Phenylephrine NON- HAZARDOUS RX WASTE Antibiotics Lidocaine Pitocin Heparin SHARPS Needles and broken ampoules Empty syringes SEWER IV dextrose Potassium Saline Sodium Calcium lactated ringers magnesium CHEMO WASTE Smith CA. Managing Pharmaceutical Waste. Journal of the Pharmaceutical Society of Wisconsin 2002;17-22.

 Save money, prevent delays and omissions  Clinical pharmacists know formulary medications  Clinical pharmacists prevent non-formulary and not-available medication orders at admission  Formulary management policies/procedures  Therapeutic interchange programs  Evaluate PAR levels for expired drugs

 Outpatient prescribing practices  Polypharmacy  Lack of follow-up  Mail order pharmacies automatic renewals  Three month supplies  Compliance  Adherence  Persistence

 Controlled substance regulation  Changes from DEA  Expected in future  Vendors  Stericycle, others …  Environmentally conscious disposal

 Therapeutic interchange  Drug classes  Pharmacodynamics of medications  Superior therapeutic alternatives  Evidence based medicine  Avoid grey market distributers

 Receive s for information only  Plan ahead  Keep adequate inventory levels  Medications dispensed daily  Accept small loss with expired medications  To stock adequate levels  Prevent drug shortages from reaching patient

 Aminophylline  Sincalade  Nalbuphine  Dextrose 25% and 50% syringes  Furosemide IV  Metoclopramide IV  Fentanyl IV  Potassium phosphate IV

 Pharmacists vital part of the healthcare team  Pharmacotherapy experts  Explain how medications work in the body  Suggest therapeutic alternatives  Eliminate therapeutic duplications

 Avoid polypharmacy  Teach common side effects  Action for severe side effects  Ethical stewardship  Medical and financial resources

 PHARMACY COST CENTER

 Collaboration  Rural health hospitals  Payers  Obtain grant money  Research  New practice models  Demonstrate added value

Lisa Anne Boothby, PharmD, BCPS Director of Pharmacy, Dukes Memorial Hospital